Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Christine L. Chaffer1,3,*, and
Robert A. Weinberg1,2,3,*
Abstract:
Metastasis causes most cancer deaths, yet this process remains one of the most enigmatic aspects of the disease. Building on new mechanistic insights emerging from recent research, we offer our perspective on the metastatic process and reflect on possible paths of future exploration. We suggest that metastasis can be portrayed as a two-phase process: The first phase involves the physical translocation of a cancer cell to a distant organ, whereas the second encompasses the ability of the cancer cell to develop into a metastatic lesion at that distant site. Although much remains to be learned about the second phase, we feel that an understanding of the first phase is now within sight, due in part to a better understanding of how cancer cell behavior can be modified by a cell-biological program called the epithelial-to-mesenchymal transition.
1 Whitehead Institute for Biomedical Research, 9 Cambridge Center, Cambridge, MA 02142, USA. 2 Department of Biology, Massachusetts Institute of Technology (MIT), Cambridge, MA 02139, USA. 3 Ludwig MIT Center for Molecular Oncology, Cambridge, MA 02139, USA.
* To whom correspondence should be addressed. E-mail: weinberg{at}wi.mit.edu (R.A.W.); chaffer{at}wi.mit.edu (C.L.C.)
The editors suggest the following Related Resources on Science sites:
In Science Magazine
INTRODUCTION TO SPECIAL ISSUE
Paula Kiberstis and Eliot Marshall (25 March 2011) Science331 (6024), 1539-a.
[DOI: 10.1126/science.331.6024.1539-a] |Full Text »|PDF »
In Science Signaling
EDITORIAL GUIDES
Elizabeth M. Adler and Nancy R. Gough (29 March 2011) Sci. Signal.4 (166), eg3.
[DOI: 10.1126/scisignal.2002014] |Abstract »|Full Text »|PDF »
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Caught in the act: revealing the metastatic process by live imaging.
Silibinin Synergizes with Histone Deacetylase and DNA Methyltransferase Inhibitors in Upregulating E-cadherin Expression Together with Inhibition of Migration and Invasion of Human Non-small Cell Lung Cancer Cells.
S. Mateen, K. Raina, C. Agarwal, D. Chan, and R. Agarwal (2013)
J. Pharmacol. Exp. Ther.
345, 206-214
|Abstract »|Full Text »|PDF »
Epoxy metabolites of docosahexaenoic acid (DHA) inhibit angiogenesis, tumor growth, and metastasis.
G. Zhang, D. Panigrahy, L. M. Mahakian, J. Yang, J.-Y. Liu, K. S. Stephen Lee, H. I. Wettersten, A. Ulu, X. Hu, S. Tam, et al. (2013)
PNAS
110, 6530-6535
|Abstract »|Full Text »|PDF »
Signaling between Transforming Growth Factor {beta} (TGF-{beta}) and Transcription Factor SNAI2 Represses Expression of MicroRNA miR-203 to Promote Epithelial-Mesenchymal Transition and Tumor Metastasis.
X. Ding, S. I. Park, L. K. McCauley, and C.-Y. Wang (2013)
J. Biol. Chem.
288, 10241-10253
|Abstract »|Full Text »|PDF »
miR-612 suppresses the invasive-metastatic cascade in hepatocellular carcinoma.
Z.-H. Tao, J.-L. Wan, L.-Y. Zeng, L. Xie, H.-C. Sun, L.-X. Qin, L. Wang, J. Zhou, Z.-G. Ren, Y.-X. Li, et al. (2013)
J. Exp. Med.
210, 789-803
|Abstract »|Full Text »|PDF »
Exchange Protein Directly Activated by cAMP (epac): A Multidomain cAMP Mediator in the Regulation of Diverse Biological Functions.
M. Schmidt, F. J. Dekker, and H. Maarsingh (2013)
Pharmacol. Rev.
65, 670-709
|Abstract »|Full Text »|PDF »
Inflammation and Hras signaling control epithelial-mesenchymal transition during skin tumor progression.
C. E. Wong, J. S. Yu, D. A. Quigley, M. D. To, K.-Y. Jen, P. Y. Huang, R. Del Rosario, and A. Balmain (2013)
Genes & Dev.
27, 670-682
|Abstract »|Full Text »|PDF »
Transcription Factor YY1 Contributes to Tumor Growth by Stabilizing Hypoxia Factor HIF-1{alpha} in a p53-Independent Manner.
S. Wu, V. Kasim, M. R. Kano, S. Tanaka, S. Ohba, Y. Miura, K. Miyata, X. Liu, A. Matsuhashi, U.-i. Chung, et al. (2013)
Cancer Res.
73, 1787-1799
|Abstract »|Full Text »|PDF »
MicroRNA-200a Promotes Anoikis Resistance and Metastasis by Targeting YAP1 in Human Breast Cancer.
S.-J. Yu, J.-Y. Hu, X.-Y. Kuang, J.-M. Luo, Y.-F. Hou, G.-H. Di, J. Wu, Z.-Z. Shen, H.-Y. Song, and Z.-M. Shao (2013)
Clin. Cancer Res.
19, 1389-1399
|Abstract »|Full Text »|PDF »
Regulation of ROCK Activity in Cancer.
M. Morgan-Fisher, U. M. Wewer, and A. Yoneda (2013)
Journal of Histochemistry & Cytochemistry
61, 185-198
|Abstract »|Full Text »|PDF »
KLF6-SV1 Drives Breast Cancer Metastasis and Is Associated with Poor Survival.
R. Hatami, A. M. Sieuwerts, S. Izadmehr, Z. Yao, R. F. Qiao, L. Papa, M. P. Look, M. Smid, J. Ohlssen, A. C. Levine, et al. (2013)
Science Translational Medicine
5, 169ra12
|Abstract »|Full Text »|PDF »
Conquering Cancer in Our Lifetime: New Diagnostic and Therapeutic Trends.
E. P. Diamandis, R. C. Bast Jr., and C. Lopez-Otin (2013)
Clin. Chem.
59, 1-3
|Full Text »|PDF »
Cell Plasticity and Heterogeneity in Cancer.
N. D. Marjanovic, R. A. Weinberg, and C. L. Chaffer (2013)
Clin. Chem.
59, 168-179
|Abstract »|Full Text »|PDF »
The V-ATPase-Inhibitor Archazolid Abrogates Tumor Metastasis via Inhibition of Endocytic Activation of the Rho-GTPase Rac1.
R. M. Wiedmann, K. von Schwarzenberg, A. Palamidessi, L. Schreiner, R. Kubisch, J. Liebl, C. Schempp, D. Trauner, G. Vereb, S. Zahler, et al. (2012)
Cancer Res.
72, 5976-5987
|Abstract »|Full Text »|PDF »
Critical role for lysyl oxidase in mesenchymal stem cell-driven breast cancer malignancy.
C. P. El-Haibi, G. W. Bell, J. Zhang, A. Y. Collmann, D. Wood, C. M. Scherber, E. Csizmadia, O. Mariani, C. Zhu, A. Campagne, et al. (2012)
PNAS
109, 17460-17465
|Abstract »|Full Text »|PDF »
Exosomes as Biomarker Enriched Microvesicles: Characterization of Exosomal Proteins Derived from a Panel of Prostate Cell Lines with Distinct AR Phenotypes.
E. Hosseini-Beheshti, S. Pham, H. Adomat, N. Li, and E. S. Tomlinson Guns (2012)
Mol. Cell. Proteomics
11, 863-885
|Abstract »|Full Text »|PDF »
Functional Genomics Identifies Drivers of Medulloblastoma Dissemination.
M. Mumert, A. Dubuc, X. Wu, P. A. Northcott, S. S. Chin, C. A. Pedone, M. D. Taylor, and D. W. Fults (2012)
Cancer Res.
72, 4944-4953
|Abstract »|Full Text »|PDF »
Circulating Tumor Cells: Getting More from Less.
J. M. Lang, B. P. Casavant, and D. J. Beebe (2012)
Science Translational Medicine
4, 141ps13
|Full Text »|PDF »
DEDD Interacts with PI3KC3 to Activate Autophagy and Attenuate Epithelial-Mesenchymal Transition in Human Breast Cancer.
Q. Lv, W. Wang, J. Xue, F. Hua, R. Mu, H. Lin, J. Yan, X. Lv, X. Chen, and Z.-W. Hu (2012)
Cancer Res.
72, 3238-3250
|Abstract »|Full Text »|PDF »
CD44s Regulates the TGF-{beta}-Mediated Mesenchymal Phenotype and Is Associated with Poor Prognosis in Patients with Hepatocellular Carcinoma.
K. Mima, H. Okabe, T. Ishimoto, H. Hayashi, S. Nakagawa, H. Kuroki, M. Watanabe, T. Beppu, M. Tamada, O. Nagano, et al. (2012)
Cancer Res.
72, 3414-3423
|Abstract »|Full Text »|PDF »
GITR Ligand Provided by Thrombopoietic Cells Inhibits NK Cell Antitumor Activity.
Met receptor tyrosine kinase signals through a cortactin-Gab1 scaffold complex, to mediate invadopodia.
C. V. Rajadurai, S. Havrylov, K. Zaoui, R. Vaillancourt, M. Stuible, M. Naujokas, D. Zuo, M. L. Tremblay, and M. Park (2012)
J. Cell Sci.
125, 2940-2953
|Abstract »|Full Text »|PDF »
gC1qR Expression in Normal and Pathologic Human Tissues: Differential Expression in Tissues of Epithelial and Mesenchymal Origin.
F. R. Dembitzer, Y. Kinoshita, D. Burstein, R. G. Phelps, M. B. Beasley, R. Garcia, N. Harpaz, S. Jaffer, S. N. Thung, P. D. Unger, et al. (2012)
Journal of Histochemistry & Cytochemistry
60, 467-474
|Abstract »|Full Text »|PDF »
Acute Activation of {beta}2-Adrenergic Receptor Regulates Focal Adhesions through {beta}Arrestin2- and p115RhoGEF Protein-mediated Activation of RhoA.
X. Ma, Y. Zhao, Y. Daaka, and Z. Nie (2012)
J. Biol. Chem.
287, 18925-18936
|Abstract »|Full Text »|PDF »
PTTG1 Oncogene Promotes Tumor Malignancy via Epithelial to Mesenchymal Transition and Expansion of Cancer Stem Cell Population.
C.-H. Yoon, M.-J. Kim, H. Lee, R.-K. Kim, E.-J. Lim, K.-C. Yoo, G.-H. Lee, Y.-H. Cui, Y. S. Oh, M. C. Gye, et al. (2012)
J. Biol. Chem.
287, 19516-19527
|Abstract »|Full Text »|PDF »
ESE3/EHF Controls Epithelial Cell Differentiation and Its Loss Leads to Prostate Tumors with Mesenchymal and Stem-like Features.
D. Albino, N. Longoni, L. Curti, M. Mello-Grand, S. Pinton, G. Civenni, G. Thalmann, G. D'Ambrosio, M. Sarti, F. Sessa, et al. (2012)
Cancer Res.
72, 2889-2900
|Abstract »|Full Text »|PDF »
NHERF1 acts as a molecular switch to program metastatic behavior and organotropism via its PDZ domains.
R. A. Cardone, M. R. Greco, M. Capulli, E. J. Weinman, G. Busco, A. Bellizzi, V. Casavola, E. Antelmi, B. Ambruosi, M. E. Dell'Aquila, et al. (2012)
Mol. Biol. Cell
23, 2028-2040
|Abstract »|Full Text »|PDF »
Vitamin D and colon cancer.
F. Pereira, M. J. Larriba, and A. Munoz (2012)
Endocr. Relat. Cancer
19, R51-R71
|Abstract »|Full Text »|PDF »
Genetic Ablation of Cav1 Differentially Affects Melanoma Tumor Growth and Metastasis in Mice: Role of Cav1 in Shh Heterotypic Signaling and Transendothelial Migration.
F. Capozza, C. Trimmer, R. Castello-Cros, S. Katiyar, D. Whitaker-Menezes, A. Follenzi, M. Crosariol, G. Llaverias, F. Sotgia, R. G. Pestell, et al. (2012)
Cancer Res.
72, 2262-2274
|Abstract »|Full Text »|PDF »
sizzled function and secreted factor network dynamics.
J. Shi, H. Zhang, R. D. Dowell, and M. W. Klymkowsky (2012)
Biology Open
1, 286-294
|Abstract »|Full Text »|PDF »
YKL-40 Is Differentially Expressed in Human Embryonic Stem Cells and in Cell Progeny of the Three Germ Layers.
C. B. Brochner, J. S. Johansen, L. A. Larsen, M. Bak, H. B. Mikkelsen, A. G. Byskov, C. Y. Andersen, and K. Mollgard (2012)
Journal of Histochemistry & Cytochemistry
60, 188-204
|Abstract »|Full Text »|PDF »
Kaposi Sarcoma Herpesvirus Promotes Endothelial-to-Mesenchymal Transition through Notch-Dependent Signaling.
P. Gasperini, G. Espigol-Frigole, P. J. McCormick, O. Salvucci, D. Maric, T. S. Uldrick, M. N. Polizzotto, R. Yarchoan, and G. Tosato (2012)
Cancer Res.
72, 1157-1169
|Abstract »|Full Text »|PDF »
A Biophysical Indicator of Vaso-occlusive Risk in Sickle Cell Disease.
D. K. Wood, A. Soriano, L. Mahadevan, J. M. Higgins, and S. N. Bhatia (2012)
Science Translational Medicine
4, 123ra26
|Abstract »|Full Text »|PDF »
Translational genomics: The challenge of developing cancer biomarkers.
The EWS/FLI Oncogene Drives Changes in Cellular Morphology, Adhesion, and Migration in Ewing Sarcoma.
A. Chaturvedi, L. M. Hoffman, A. L. Welm, S. L. Lessnick, and M. C. Beckerle (2012)
Genes & Cancer
3, 102-116
|Abstract »|Full Text »|PDF »
A Novel FoxM1-Caveolin Signaling Pathway Promotes Pancreatic Cancer Invasion and Metastasis.
C. Huang, Z. Qiu, L. Wang, Z. Peng, Z. Jia, C. D. Logsdon, X. Le, D. Wei, S. Huang, and K. Xie (2012)
Cancer Res.
72, 655-665
|Abstract »|Full Text »|PDF »
IGDB.NSCLC: integrated genomic database of non-small cell lung cancer.
S. Kao, C.-K. Shiau, D.-L. Gu, C.-M. Ho, W.-H. Su, C.-F. Chen, C.-H. Lin, and Y.-S. Jou (2012)
Nucleic Acids Res.
40, D972-D977
|Abstract »|Full Text »|PDF »
Association of Rho-associated protein kinase 1 with E-cadherin complexes is mediated by p120-catenin.
A. L. Smith, M. R. Dohn, M. V. Brown, and A. B. Reynolds (2012)
Mol. Biol. Cell
23, 99-110
|Abstract »|Full Text »|PDF »
A Dormant State Modulated by Osmotic Pressure Controls Clonogenicity of Prostate Cancer Cells.
M. Havard, F. Dautry, and T. Tchenio (2011)
J. Biol. Chem.
286, 44177-44186
|Abstract »|Full Text »|PDF »
Host-Derived Pericytes and Sca-1+ Cells Predominate in the MART-1- Stroma Fraction of Experimentally Induced Melanoma.
J. H. Trevino-Villarreal, D. A. Cotanche, R. Sepulveda, M. E. Bortoni, O. Manneberg, T. Udagawa, and R. A. Rogers (2011)
Journal of Histochemistry & Cytochemistry
59, 1060-1075
|Abstract »|Full Text »|PDF »
Inactivation of Mirk/Dyrk1b Kinase Targets Quiescent Pancreatic Cancer Cells.
D. Z. Ewton, J. Hu, M. Vilenchik, X. Deng, K.-c. Luk, A. Polonskaia, A. F. Hoffman, K. Zipf, J. F. Boylan, and E. A. Friedman (2011)
Mol. Cancer Ther.
10, 2104-2114
|Abstract »|Full Text »|PDF »
Hypoxia-inducible factor 1 is a master regulator of breast cancer metastatic niche formation.
C. C.-L. Wong, D. M. Gilkes, H. Zhang, J. Chen, H. Wei, P. Chaturvedi, S. I. Fraley, C.-M. Wong, U.-S. Khoo, I. O.-L. Ng, et al. (2011)
PNAS
108, 16369-16374
|Abstract »|Full Text »|PDF »
VEGF-A and Tenascin-C produced by S100A4+ stromal cells are important for metastatic colonization.
J. T. O'Connell, H. Sugimoto, V. G. Cooke, B. A. MacDonald, A. I. Mehta, V. S. LeBleu, R. Dewar, R. M. Rocha, R. R. Brentani, M. B. Resnick, et al. (2011)
PNAS
108, 16002-16007
|Abstract »|Full Text »|PDF »
HOXC8-Dependent Cadherin 11 Expression Facilitates Breast Cancer Cell Migration through Trio and Rac.
Y. Li, Z. Guo, H. Chen, Z. Dong, Z. K. Pan, H. Ding, S.-B. Su, and S. Huang (2011)
Genes & Cancer
2, 880-888
|Abstract »|Full Text »|PDF »
The Emerging Cell Biology of Thyroid Stem Cells.
T. F. Davies, R. Latif, N. C. Minsky, and R. Ma (2011)
J. Clin. Endocrinol. Metab.
96, 2692-2702
|Abstract »|Full Text »|PDF »
A Cell-Based High-Content Screening Assay Reveals Activators and Inhibitors of Cancer Cell Invasion.
M. Quintavalle, L. Elia, J. H. Price, S. Heynen-Genel, and S. A. Courtneidge (2011)
Science Signaling
4, ra49
|Abstract »|Full Text »|PDF »